The respiratory cancers, including lung cancer and head and neck cancer, are common causes of morbidity and mortality. The Dana-Farber Cancer Institute has committed major clinical and laboratory resources for the study and control of these tumors. Specifically, we have developed multidisciplinary clinics for both diseases. The Farber Institute has a major commitment to therapeutic research, particularly in areas of drug development and pharmacology. Much of this work relates to the respiratory cancers. Hence, the construct and title of this Program Project Grant is """"""""The Clinical and Experimental Pharmacology of Respiratory Cancers."""""""" A major treatment strategy includes neoadjuvant chemotherapy regimens for the respiratory cancers. We have developed, and have under study and application, modulators--that is, agents that can improve the chemotherapeutic index of selected chemotherapeutic agents. We have developed new agents or analogs including antimitochondrial agents; novel folic acid antagonists; and platinum dye complexes. We have accomplished, young investigators working in the oncogene-growth factor arena with specific relevance to the respiratory cancers. These selected programs will help us to find and develop therapeutic targets, and provide a better understanding of the disease, including clinical correlates such as response to therapy and prognosis. Finally, we are intrigued with our evidence and that of others that significant beginning progress has been achieved in the treatment of these tumors. We feel it is timely to develop an integrated clinical and laboratory approach to accelerate this progress.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA019589-17
Application #
2086781
Study Section
Special Emphasis Panel (SRC (E1))
Project Start
1976-06-30
Project End
1995-03-31
Budget Start
1994-04-01
Budget End
1995-03-31
Support Year
17
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02215
Rosowsky, A; Vaidya, C M; Bader, H et al. (1997) Analogues of N alpha-(4-amino-4-deoxypteroyl)-N delta-hemiphthaloyl-L-ornithine (PT523) modified in the side chain: synthesis and biological evaluation. J Med Chem 40:286-99
Dreyfuss, A I; Clark, J R; Norris, C M et al. (1996) Docetaxel: an active drug for squamous cell carcinoma of the head and neck. J Clin Oncol 14:1672-8
Teicher, B A; Holden, S A; Ara, G et al. (1996) Comparison of several antiangiogenic regimens alone and with cytotoxic therapies in the Lewis lung carcinoma. Cancer Chemother Pharmacol 38:169-77
Bharti, A K; Olson, M O; Kufe, D W et al. (1996) Identification of a nucleolin binding site in human topoisomerase I. J Biol Chem 271:1993-7
Robinson, M F; Dupuis, N P; Kusumoto, T et al. (1995) Increased tumor oxygenation and radiation sensitivity in two rat tumors by a hemoglobin-based, oxygen-carrying preparation. Artif Cells Blood Substit Immobil Biotechnol 23:431-8
Teicher, B A; Dupuis, N P; Emi, Y et al. (1995) Increased efficacy of chemo- and radio-therapy by a hemoglobin solution in the 9L gliosarcoma. In Vivo 9:11-8
Shapiro, C L; Dezube, B J; Tretyakov, O et al. (1995) Dose escalation of N,N',N""-triethylenethiophosphoramide combined with pentoxifylline for advanced breast cancer. Clin Cancer Res 1:791-6
Shapiro, G I; Edwards, C D; Kobzik, L et al. (1995) Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines. Cancer Res 55:505-9
Chen, G; Wright, J E; Rosowsky, A (1995) Dihydrofolate reductase binding and cellular uptake of nonpolyglutamatable antifolates: correlates of cytotoxicity toward methotrexate-sensitive and -resistant human head and neck squamous carcinoma cells. Mol Pharmacol 48:758-65
Teicher, B A; Holden, S A; Ara, G et al. (1995) Influence of an anti-angiogenic treatment on 9L gliosarcoma: oxygenation and response to cytotoxic therapy. Int J Cancer 61:732-7

Showing the most recent 10 out of 145 publications